A Randomized, Double-blind, Placebo Controlled, Safety, Tolerability, and Pharmacokinetic Dose Escalation Study of DFA-02 in Patients Undergoing Colorectal Surgery.
Phase of Trial: Phase I/II
Latest Information Update: 28 Oct 2014
At a glance
- Drugs Gentamicin/vancomycin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Postoperative infections; Vancomycin-resistant enterococcal infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Dr Reddys Laboratories
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2013 Planned End Date changed from 1 Dec 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 04 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.